qRT–PCR was used to validate the expression of the hub DE-PRG genes, including CASP8, BAK, BAX, CYCS, TP53, and GSDMB in human prostate cancer tissues and matched normal prostate tissues. This evidence concerns the gene TP53 and prostate cancer.